USD 14.21
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| NEO | 1.6 | -19.9 | -19.0 | 5.3 | -8.3 | -8.1 | -39.3 | -55.7 | 278.9 | 3204.7 |
| S&P 500 | 1.0 | 1.8 | -0.9 | 2.7 | 7.3 | 26.5 | 31.0 | 80.1 | 196.5 | 33856.2 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | NEO |
| name | NeoGenomics, Inc. |
| price | 14.21 |
| changes percentage | 1.6452 |
| change | 0.23 |
| day low | 14.01 |
| day high | 14.57 |
| year high | 19.11 |
| year low | 12.13 |
| market cap | 1824009796 |
| price avg 50 | 16.5216 |
| price avg 200 | 15.15555 |
| exchange | NASDAQ |
| volume | 881322 |
| avg volume | 840237 |
| open | 14.12 |
| previous close | 13.98 |
| eps | -0.61 |
| pe | -23.3 |
| earnings announcement | 2025-02-18T10:59:00.000+0000 |
| shares outstanding | 128360999 |
| timestamp | 2025-01-17 21:00:00 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001077183 | |||
| revenue | 591643000 | 509728000 | 16.07 |
| gross profit | 244604000 | 187896000 | 30.18 |
| gross profit ratio | 0.41 | 0.37 | 12.16 |
| research and development expenses | 27309000 | 30326000 | -9.95 |
| operating expenses | 352340000 | 341003000 | 3.32 |
| interest income | 16902000 | 6075000 | 178.22 |
| interest expense | 6907000 | 1506000 | 358.63 |
| ebitda | -17607000 | -78631000 | 77.61 |
| ebitdaratio | -0.03 | -0.16 | 81.92 |
| operating income | -107736000 | -153107000 | 29.63 |
| operating income ratio | -0.18 | -0.3 | 39.38 |
| net income | -87968000 | -144250000 | 39.02 |
| net income ratio | -0.15 | -0.28 | 47.46 |
| eps | -0.7 | -1.16 | 39.66 |
Revenue Growth: revenue increased to 592 million in 2023 from 510 million in 2022 representing a change of 16.07%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 245 million in 2023 from 188 million in 2022 representing a change of 30.18%. This indicates a sales profitability growth, which is a positive sign for the company.
Net Income: Net income increased to -88 million in 2023 from -144 million in 2022 representing a change of 39.02%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to -0.7 in 2023 from -0.7 in 2022 representing a change of 39.66%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Research and Development (R&D) Expenses: R&D Expenses decreased to 27 million in 2023 from 30 million in 2022 representing a change of -9.95%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.
Operating Expenses: Operating Expenses increased to 352 million in 2023 from 341 million in 2022 representing a change of 3.32%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -18 million in 2023 from -79 million in 2022 representing a change of 77.61%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Operating Income: Operating income decreased to -108 million in 2023 from -153 million in 2022 representing a change of 29.63%. The decrease in operating income indicates worse operational performance and decreased profitability.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001077183 | |||
| revenue | 167824000 | 164502000 | 2.02 |
| gross profit | 74880000 | 69042000 | 8.46 |
| gross profit ratio | 0.45 | 0.42 | 6.31 |
| research and development expenses | 7684000 | 7886000 | -2.56 |
| operating expenses | 95068000 | 89439000 | 6.29 |
| interest income | 4673000 | 4592000 | 1.76 |
| interest expense | 1642000 | 1666000 | -1.44 |
| ebitda | 1778000 | 756000 | 135.19 |
| ebitdaratio | 0.01 | -0.01 | 176.11 |
| operating income | -21197000 | -20397000 | -3.92 |
| operating income ratio | -0.13 | -0.12 | -1.87 |
| net income | -17699000 | -18642000 | 5.06 |
| net income ratio | -0.11 | -0.11 | 6.94 |
| eps | -0.14 | -0.15 | 6.67 |
Revenue Growth: revenue increased to 168 million in 2024Q3 from 165 million in 2024Q2 representing a change of 2.02%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 75 million in 2024Q3 from 69 million in 2024Q2 representing a change of 8.46%. This indicates a sales profitability growth, which is a positive sign for the company.
Operating Income: Operating income increased to -21 million in 2024Q3 from -20 million in 2024Q2 representing a change of -3.92%. The increase in operating income indicates better operational performance and increased profitability.
Earnings per Share (EPS): EPS increased to -0.14 in 2024Q3 from -0.14 in 2024Q2 representing a change of 6.67%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Research and Development (R&D) Expenses: R&D Expenses decreased to 8 million in 2024Q3 from 8 million in 2024Q2 representing a change of -2.56%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.
Operating Expenses: Operating Expenses increased to 95 million in 2024Q3 from 89 million in 2024Q2 representing a change of 6.29%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 2 million in 2024Q3 from 1 million in 2024Q2 representing a change of 135.19%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Net Income: Net income decreased to -18 million in 2024Q3 from -19 million in 2024Q2 representing a change of 5.06%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001077183 | |||
| total assets | 1681229000 | 1740034000 | -3.38 |
| total liabilities | 739692000 | 742011000 | -0.31 |
| total equity | 941537000 | 998023000 | -5.66 |
| cash and cash equivalents | 342488000 | 263180000 | 30.13 |
| short term investments | 72715000 | 174809000 | -58.40 |
| long term investments | 0 | 31000 | -100.00 |
| total current assets | 596812000 | 605291000 | -1.40 |
| total non current assets | 1084417000 | 1134743000 | -4.44 |
| total current liabilities | 96304000 | 89932000 | 7.09 |
| total non current liabilities | 643388000 | 652079000 | -1.33 |
| common stock | 127000 | 127000 | 0.00 |
| retained earnings | -247055000 | -159087000 | -55.30 |
| total debt | 611679000 | 610928000 | 0.12 |
Total Assets: Total Assets decreased to 1,681 million in 2023 from 1,740 million in 2022 representing a change of -3.38%. Suggesting a decrease in asset holdings.
Total Equity: Total Equity decreased to 942 million in 2023 from 998 million in 2022 representing a change of -5.66%. This indicates a decrease in shareholders' equity.
Short Term Investments: Short Term Investments decreased to 73 million in 2023 from 175 million in 2022 representing a change of -58.4%. This indicates a decrease in short-term investment holdings.
Total Current Assets: Total Current Assets decreased to 597 million in 2023 from 605 million in 2022 representing a change of -1.4%. This indicates a worsen liquidity position.
Total Current Liabilities: Total Current Liabilities increased to 96 million in 2023 from 90 million in 2022 representing a change of 7.09%. This indicates a higher short-term debt burden.
Retained Earnings: Retained Earnings decreased to -247 million in 2023 from -159 million in 2022 representing a change of -55.3%. This indicates an accumulated losses.
Total Debt: Total Debt increased to 612 million in 2023 from 611 million in 2022 representing a change of 0.12%. This indicates an increase in overall debt burden.
Total Liabilities: Total Liabilities decreased to 740 million in 2023 from 742 million in 2022 representing a change of -0.31%. This indicates a decrease in overall liabilities.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 342 million in 2023 from 263 million in 2022 representing a change of 30.13%. This indicates an increase in available liquid assets.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001077183 | |||
| total assets | 1641111000 | 1643277000 | -0.13 |
| total liabilities | 732901000 | 727393000 | 0.76 |
| total equity | 908210000 | 915884000 | -0.84 |
| cash and cash equivalents | 361992000 | 355085000 | 1.95 |
| short term investments | 25821000 | 32770000 | -21.21 |
| long term investments | 0 | -23015000 | 100.00 |
| total current assets | 590241000 | 584203000 | 1.03 |
| total non current assets | 1050870000 | 1059074000 | -0.77 |
| total current liabilities | 296406000 | 289959000 | 2.22 |
| total non current liabilities | 436494999 | 437434000 | -0.21 |
| common stock | 128000 | 128000 | 0.00 |
| retained earnings | -310457000 | -292758000 | -6.05 |
| total debt | 606268000 | 606518000 | -0.04 |
Total Assets: Total Assets decreased to 1,641 million in 2024Q3 from 1,643 million in 2024Q2 representing a change of -0.13%. Suggesting a decrease in asset holdings.
Total Liabilities: Total Liabilities increased to 733 million in 2024Q3 from 727 million in 2024Q2 representing a change of 0.76%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to 908 million in 2024Q3 from 916 million in 2024Q2 representing a change of -0.84%. This indicates a decrease in shareholders' equity.
Short Term Investments: Short Term Investments decreased to 26 million in 2024Q3 from 33 million in 2024Q2 representing a change of -21.21%. This indicates a decrease in short-term investment holdings.
Total Current Liabilities: Total Current Liabilities increased to 296 million in 2024Q3 from 290 million in 2024Q2 representing a change of 2.22%. This indicates a higher short-term debt burden.
Retained Earnings: Retained Earnings decreased to -310 million in 2024Q3 from -293 million in 2024Q2 representing a change of -6.05%. This indicates an accumulated losses.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 362 million in 2024Q3 from 355 million in 2024Q2 representing a change of 1.95%. This indicates an increase in available liquid assets.
Total Current Assets: Total Current Assets increased to 590 million in 2024Q3 from 584 million in 2024Q2 representing a change of 1.03%. This indicates a better liquidity position.
Total Debt: Total Debt decreased to 606 million in 2024Q3 from 607 million in 2024Q2 representing a change of -0.04%. This indicates a reduction in overall debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001077183 | |||
| net change in cash | 79308000 | -53647000 | 247.83 |
| operating cash flow | -1953000 | -65993000 | 97.04 |
| free cash flow | -30705000 | -96884000 | 68.31 |
| capital expenditure | -28752000 | -30891000 | 6.92 |
| depreciation and amortization | 72583000 | 69430000 | 4.54 |
| deferred income tax | 0 | -16098000 | 100.00 |
| stock based compensation | 24633000 | 24672000 | -0.16 |
| accounts payables | -4547000 | 2795000 | -262.68 |
| inventory | -454000 | -1100000 | 58.73 |
| acquisitions net | 0 | 0 | NaN |
| investments in property plant and equipment | -28752000 | -30891000 | 6.92 |
| net cash used for investing activites | 76707000 | 517000 | 14736.94 |
| debt repayment | -70000 | 0 | NaN |
| common stock issued | 4624000 | 12587000 | -63.26 |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 4554000 | 11829000 | -61.50 |
| cash at end of period | 342488000 | 263180000 | 30.13 |
| accounts receivables | -11516000 | -7581000 | -51.91 |
| cash at beginning of period | 263180000 | 316827000 | -16.93 |
Net Change in Cash: Net Change in Cash increased to 79 million in 2023 from -54 million in 2022 representing a change of 247.83%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to -2 million in 2023 from -66 million in 2022 representing a change of 97.04%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to -31 million in 2023 from -97 million in 2022 representing a change of 68.31%. This indicates an increase in cash generated after accounting for capital expenditures.
Stock-Based Compensation: Stock-Based Compensation decreased to 25 million in 2023 from 25 million in 2022 representing a change of -0.16%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Receivables: Accounts Receivables decreased to -12 million in 2023 from -8 million in 2022 representing a change of -51.91%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.
Capital Expenditure: Capital Expenditure increased to -29 million in 2023 from -31 million in 2022 representing a change of 6.92%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Deferred Income Tax: Deferred Income Tax increased to 0 million in 2023 from -16 million in 2022 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.
Accounts Payables: The absolute value of Accounts Payables increased to 5 million in 2023 from 3 million in 2022 representing a change of -262.68%. This indicates that the company has increased its outstanding obligations to its suppliers.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001077183 | |||
| operating cash flow | 9246000 | 13892000 | -33.44 |
| free cash flow | -1553000 | 814000 | -290.79 |
| capital expenditure | -10799000 | -13078000 | 17.43 |
| depreciation and amortization | 17985000 | 18107000 | -0.67 |
| deferred income tax | 795000 | 0 | NaN |
| stock based compensation | 8470000 | 8841000 | -4.20 |
| accounts receivables | -4848000 | -6301000 | 23.06 |
| accounts payables | 5037000 | -4847000 | 203.92 |
| inventory | -1243000 | -3001000 | 58.58 |
| acquisitions net | 0 | 0 | NaN |
| investments in property plant and equipment | -10799000 | -13078000 | 17.43 |
| net cash used for investing activites | -3516000 | 7313000 | -148.08 |
| debt repayment | 0 | 0 | NaN |
| common stock issued | 1177000 | 1966000 | -40.13 |
| common stock repurchased | 0 | 0 | NaN |
| dividends paid | 0 | 0 | NaN |
| net cash used provided by financing activities | 1177000 | 1966000 | -40.13 |
| net change in cash | 6907000 | 23171000 | -70.19 |
| cash at end of period | 361992000 | 355085000 | 1.95 |
| cash at beginning of period | 355085000 | 331914000 | 6.98 |
Net Change in Cash: Net Change in Cash decreased to 7 million in 2024Q3 from 23 million in 2024Q2 representing a change of -70.19%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow decreased to 9 million in 2024Q3 from 14 million in 2024Q2 representing a change of -33.44%. This indicates that the company generated less cash from its core business operations.
Free Cash Flow: Free Cash Flow decreased to -2 million in 2024Q3 from 1 million in 2024Q2 representing a change of -290.79%. This indicates a decrease in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure increased to -11 million in 2024Q3 from -13 million in 2024Q2 representing a change of 17.43%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Deferred Income Tax: Deferred Income Tax increased to 1 million in 2024Q3 from 0 million in 2024Q2 representing a change of nan%. This indicates that the company's tax liability for future periods has increased.
Accounts Payables: The absolute value of Accounts Payables increased to 5 million in 2024Q3 from 5 million in 2024Q2 representing a change of 203.92%. This indicates that the company has increased its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables increased to -5 in 2024Q3 from -6 million in 2024Q2 representing a change of 23.06%. This suggests that the company is less capable of collecting payments from its customers.
Stock-Based Compensation: Stock-Based Compensation decreased to 8 million in 2024Q3 from 9 million in 2024Q2 representing a change of -4.2%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q3 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-31 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 4.71 | 4.1 | 14.88 |
| net income per share | -0.7 | -1.16 | 39.64 |
| operating cash flow per share | -0.02 | -0.53 | 97.07 |
| free cash flow per share | -0.24 | -0.78 | 68.63 |
| cash per share | 3.31 | 3.53 | -6.17 |
| book value per share | 7.5 | 8.03 | -6.63 |
| tangible book value per share | 0.36 | 0.54 | -32.57 |
| shareholders equity per share | 7.5 | 8.03 | -6.63 |
| interest debt per share | 4.93 | 4.93 | -0.03 |
| market cap | 2030622360 | 1147765080 | 76.92 |
| enterprise value | 2299813360 | 1495513080 | 53.78 |
| pe ratio | -23.08 | -7.96 | -190.11 |
| price to sales ratio | 3.43 | 2.25 | 52.42 |
| pocfratio | -1039.75 | -17.39 | -5878.22 |
| pfcf ratio | -66.13 | -11.85 | -458.24 |
| pb ratio | 2.16 | 1.15 | 87.53 |
| ptb ratio | 2.16 | 1.15 | 87.53 |
| ev to sales | 3.89 | 2.93 | 32.49 |
| enterprise value over ebitda | -130.62 | -19.02 | -586.77 |
| ev to operating cash flow | -1177.58 | -22.66 | -5096.35 |
| ev to free cash flow | -74.9 | -15.44 | -385.23 |
| earnings yield | -0.04 | -0.13 | 65.53 |
| free cash flow yield | -0.02 | -0.08 | 82.09 |
| debt to equity | 0.65 | 0.61 | 6.13 |
| debt to assets | 0.36 | 0.35 | 3.62 |
| net debt to ebitda | -15.29 | -4.42 | -245.70 |
| current ratio | 6.2 | 6.73 | -7.92 |
| interest coverage | -15.6 | -101.66 | 84.66 |
| income quality | 0.02 | 0.46 | -95.15 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.41 | 0.48 | -13.94 |
| research and ddevelopement to revenue | 0.05 | 0.06 | -22.42 |
| intangibles to total assets | 0.53 | 0.54 | -0.41 |
| capex to operating cash flow | -14.72 | -0.47 | -3045.08 |
| capex to revenue | 0.05 | 0.06 | -19.81 |
| capex to depreciation | 0.4 | 0.44 | -10.97 |
| stock based compensation to revenue | 0.04 | 0.05 | -13.98 |
| graham number | 10.88 | 14.49 | -24.93 |
| roic | -0.06 | -0.08 | 26.65 |
| return on tangible assets | -0.11 | -0.18 | 37.18 |
| graham net net | -1.7 | -1.63 | -4.79 |
| working capital | 500508000 | 515359000 | -2.88 |
| tangible asset value | 45643000 | 66997000 | -31.87 |
| net current asset value | -142880000 | -136720000 | -4.51 |
| invested capital | 1580183000 | 1644993000 | -3.94 |
| average receivables | 125487500 | 115920500 | 8.25 |
| average payables | 20422000 | 19215500 | 6.28 |
| average inventory | 24216500 | 23836000 | 1.60 |
| days sales outstanding | 80.98 | 85.72 | -5.53 |
| days payables outstanding | 21.39 | 23.26 | -8.06 |
| days of inventory on hand | 25.41 | 27.53 | -7.73 |
| receivables turnover | 4.51 | 4.26 | 5.85 |
| payables turnover | 17.07 | 15.69 | 8.77 |
| inventory turnover | 14.37 | 13.26 | 8.37 |
| roe | -0.09 | -0.14 | 35.36 |
| capex per share | 0.23 | 0.25 | -7.88 |
ROE: Return on Equity (ROE) increased to -0.09 on 2023-12-31 from -0.14 on 2022-12-31, representing a change of 35.36%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -23.08 on 2023-12-31 from -7.96 on 2022-12-31, representing a change of -190.11%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio decreased to 6.20 on 2023-12-31 from 6.73 on 2022-12-31, representing a change of -7.92%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.65 on 2023-12-31 from 0.61 on 2022-12-31, representing a change of 6.13%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
| 2024-09-30 Q3 | 2024-06-30 Q2 | Q/Q change % | |
|---|---|---|---|
| NEO | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 1.32 | 1.3 | 1.58 |
| net income per share | -0.14 | -0.15 | 5.47 |
| operating cash flow per share | 0.07 | 0.11 | -33.73 |
| free cash flow per share | -0.01 | 0.01 | -289.96 |
| cash per share | 3.05 | 3.07 | -0.44 |
| book value per share | 7.15 | 7.25 | -1.27 |
| tangible book value per share | 0.29 | 0.29 | 1.43 |
| shareholders equity per share | 7.15 | 7.25 | -1.27 |
| interest debt per share | 4.79 | 4.81 | -0.48 |
| market cap | 1872556750 | 1760821650 | 6.35 |
| enterprise value | 2116832750 | 2012254650 | 5.20 |
| pe ratio | -26.45 | -23.61 | -12.01 |
| price to sales ratio | 11.16 | 10.7 | 4.24 |
| pocfratio | 202.53 | 126.75 | 59.78 |
| pfcf ratio | -1205.77 | 2163.17 | -155.74 |
| pb ratio | 2.06 | 1.92 | 7.24 |
| ptb ratio | 2.06 | 1.92 | 7.24 |
| ev to sales | 12.61 | 12.23 | 3.11 |
| enterprise value over ebitda | 1190.57 | 2661.71 | -55.27 |
| ev to operating cash flow | 228.95 | 144.85 | 58.06 |
| ev to free cash flow | -1363.06 | 2472.06 | -155.14 |
| earnings yield | -0.01 | -0.01 | 10.72 |
| free cash flow yield | -0.0 | 0.0 | -279.40 |
| debt to equity | 0.67 | 0.66 | 0.80 |
| debt to assets | 0.37 | 0.37 | 0.09 |
| net debt to ebitda | 137.39 | 332.58 | -58.69 |
| current ratio | 1.99 | 2.01 | -1.16 |
| interest coverage | -12.91 | -12.24 | -5.44 |
| income quality | -0.52 | -0.75 | 29.90 |
| dividend yield | 0 | 0 | NaN |
| payout ratio | 0 | 0 | NaN |
| sales general and administrative to revenue | 0.4 | 0.38 | 3.66 |
| research and ddevelopement to revenue | 0.05 | 0.05 | -4.49 |
| intangibles to total assets | 0.53 | 0.54 | -0.82 |
| capex to operating cash flow | 1.17 | 0.94 | 24.07 |
| capex to revenue | 0.06 | 0.08 | -19.06 |
| capex to depreciation | 0.6 | 0.72 | -16.87 |
| stock based compensation to revenue | 0.05 | 0.05 | -6.09 |
| graham number | 4.74 | 4.9 | -3.39 |
| roic | -0.01 | -0.01 | -5.67 |
| return on tangible assets | -0.02 | -0.02 | 5.82 |
| graham net net | -1.73 | -1.72 | -0.16 |
| working capital | 293835000 | 294244000 | -0.14 |
| tangible asset value | 37402000 | 36714000 | 1.87 |
| net current asset value | -142660000 | -143190000 | 0.37 |
| invested capital | 1339123000 | 1349243000 | -0.75 |
| average receivables | 149004500 | 143548000 | 3.80 |
| average payables | 16850000 | 17761000 | -5.13 |
| average inventory | 23835500 | 21767000 | 9.50 |
| days sales outstanding | 81.21 | 80.2 | 1.26 |
| days payables outstanding | 15.99 | 16.2 | -1.31 |
| days of inventory on hand | 23.68 | 21.89 | 8.21 |
| receivables turnover | 1.11 | 1.12 | -1.25 |
| payables turnover | 5.63 | 5.55 | 1.33 |
| inventory turnover | 3.8 | 4.11 | -7.58 |
| roe | -0.02 | -0.02 | 4.26 |
| capex per share | 0.09 | 0.1 | -17.78 |
ROE: Return on Equity (ROE) decreased to -0.02 on 2024-09-30 Q3 from -0.02 on 2024-06-30 Q2, representing a change of 4.26%. Suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -26.45 on 2024-09-30 Q3 from -23.61 on 2024-06-30 Q2, representing a change of -12.01%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio decreased to 1.99 on 2024-09-30 Q3 from 2.01 on 2024-06-30 Q2, representing a change of -1.16%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.67 on 2024-09-30 Q3 from 0.66 on 2024-06-30 Q2, representing a change of 0.80%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
Negative Sentiment: Discounted Cash Flow value is -12.59 which is lower than current price 14.21, indicates the company may be overvalued.
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2025-01-15 11:51:08
NeoGenomics stock jumped Wednesday after the company issued a strong 2025 outlook. That partially reversed a recent selloff.
Sentiment: Neutral
Publish Date: 2025-01-15 07:05:00
FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics today provided financial guidance for fiscal year 2025 and updated its Long-Range Financial Plan.
Sentiment: Positive
Publish Date: 2025-01-15 05:56:08
NeoGenomics (NEO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Sentiment: Positive
Publish Date: 2025-01-14 07:30:00
Pairing Adaptive Biotechnologies' clonoSEQ MRD results with NeoGenomics' COMPASS and CHART assessment services empowers clinicians and patients with meaningful insights across the treatment continuum Pairing Adaptive Biotechnologies' clonoSEQ MRD results with NeoGenomics' COMPASS and CHART assessment services empowers clinicians and patients with meaningful insights across the treatment continuum
Sentiment: Positive
Publish Date: 2025-01-10 07:05:00
FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics' Chris Smith will retire as CEO and board member, effective April 1, 2025. Tony Zook will assume the role of CEO at that time.
Sentiment: Positive
Publish Date: 2025-01-07 09:30:00
TORONTO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (T S X V : NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce the launch of an advanced high-performance silicon anode product called NBMSiDE® P-300 with breakthrough battery capacity. Alongside its core focus on electric vehicles and electronics, NEO is expanding its strategic downstream focus to the space and eVTOL industries through solid-state batteries.
Sentiment: Neutral
Publish Date: 2025-01-06 07:55:00
FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will attend the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco.
Sentiment: Positive
Publish Date: 2024-12-30 13:01:09
NeoGenomics (NEO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Sentiment: Positive
Publish Date: 2024-12-19 09:30:00
TORONTO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (T S X V : NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce the joint development agreement (the “Agreement” or “JDA”) with a North American battery cell manufacturer (“JDA Partner”) effective November 30, 2024. This collaboration aims to develop and enhance the performance of silicon anode materials for specialty electric automotive and mobility applications. There are no material terms or considerations as part of this JDA.
Sentiment: Neutral
Publish Date: 2024-12-11 08:05:00
FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics' newly published study shows how ctDNA in MRD may enable earlier identification of disease recurrence for high-risk melanoma patients.
Sentiment: Neutral
Publish Date: 2024-12-09 08:10:00
FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will present research on hematologic malignancies and the prognostic effects of microenvironment signatures in primary CNS lymphoma at ASH.
Sentiment: Positive
Publish Date: 2024-12-05 07:00:00
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ConcertAI and NeoGenomics (NASDAQ: NEO) announce a joint software-as-a-service solution in hematological malignancies for research analytics, clinical trial design, and clinical trial operational optimization. CTO-H provides a research data solution that is unprecedented in its scale, longitudinality and biomarker depth. CTO-H is a major outcome of the collaboration jointly announced on Jan. 8, 2024, and the more recent joint research completed and scheduled f.
Sentiment: Neutral
Publish Date: 2024-12-03 12:04:00
TORONTO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “C o mpan y”) (T S X V : NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, wishes to provide complete assurance and confirmation to its stakeholders that the recent declaration of emergency martial law in South Korea does not and will not impact the Company's operations and progress at its Research and Development (R&D) Scale-Up Centre located in the country. As of 1 AM KT, December 4, 2024, the South Korean National Assembly has passed a resolution to end the declaration of emergency martial law.
Sentiment: Positive
Publish Date: 2024-12-03 08:12:00
TORONTO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “C o mpan y”) (T S X V : NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, announces that Roberto Fia has resigned from the Company's Board of Directors effective November 29, 2024. NEO would like to thank him for his contributions to date.
Sentiment: Positive
Publish Date: 2024-11-28 09:30:00
TORONTO, Nov. 28, 2024 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (T S X V : NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce the signing of a Memorandum of Understanding (“MOU”) with OCSiAl LLC (“OCSiAl”), the world's largest industrial producer of single wall carbon nanotubes (SWCNTs), on October 23, 2024. OCSiAl will supply NEO with SWCNT products to manufacture a high-specification model of NEO's polymer-coated silicon anodes. There are no material terms or considerations regarding this MOU.
Sentiment: Positive
Publish Date: 2024-11-25 09:20:00
TORONTO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “C o mpan y”) (T S X V : NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce that the Company will be holding a corporate webinar on Thursday, December 5, 2024, at 7 PM EDT / 4 PM PDT / 9 AM KT.
Sentiment: Positive
Publish Date: 2024-11-22 08:34:00
TORONTO, Nov. 22, 2024 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “C o mpan y”) (T S X V : NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce the appointment of Mr. Seok Hyung Lee as a new independent director of the Company and the South Korean subsidiary, NBM Korea Co., Ltd. (“NBM Korea”), effective November 22, 2024.
Sentiment: Positive
Publish Date: 2024-11-20 10:30:00
TORONTO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- NEO Battery Materials Ltd. (“NEO” or the “C o mpan y”) (T S X V : NBM) (OTC: NBMFF), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to announce that the Company has been awarded as a consortium partner along with major battery value chain companies and universities in a CAD$20M recycled silicon battery project organized by the South Korean Ministry of Trade, Industry, and Energy.
Sentiment: Neutral
Publish Date: 2024-11-12 00:11:06
The head of Airbus China said on Tuesday that the certification for its A330NEO plane in China was going smoothly and that the first delivery in the country could come in 2025.
Sentiment: Neutral
Publish Date: 2024-11-08 07:00:00
FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference in New York City.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
